Innovations in Data Capture Transforming Trial Delivery
Our CEO and CTO recently collaborated on an excellent piece in Applied Clinical Trials on the future of EHR2EDC with thought leaders from AstraZeneca and Sanofi.
More DetailsIgniteData collaborates with AstraZeneca
IgniteData, the Reading-based DigiHealth start-up, has today announced a new collaboration with AstraZeneca.
More DetailsIgniteData receive part of £90m continuity support
IgniteData are set to benefit from a continuity support package providing businesses with up to £250,000 to mitigate the effects of COVID-19.
More DetailsDeloitte recognise IgniteData in ‘The future of pharma services’ M&A Report
Advancements in data science are significantly shortening timeframes for clinical trials, enabling faster drug approvals and improving chances for success.
More DetailsIgniteData receive part of £40m boost for cutting-edge start-ups
IgniteData, are set to benefit from a £40 million government investment to drive forward new technological advances.
More DetailsTransformational software will speed up clinical study delivery
IgniteData, co-funded by the UK’s innovation agency, Innovate UK, and in collaboration with NICE DataLab, is developing ground-breaking software.
More DetailsIndustry News: Real-World Evidence from Mobile Devices, the Opioid Crisis, & More
Keeping up with what’s going on in the industry can be a bit of a headache; there are new studies coming out every day and new initiatives launching all the time.
More DetailsIndustry News: Soliris, a Shaky Cardiovascular Treatment, and How Pharma Is Changing Due to a Demand for RWE
Keeping up with what’s going on in the industry can be a bit of a headache; there are new studies coming out every day and new initiatives launching all the time.
More DetailsReal-World Studies Are Being Used in the Classroom
Real-World Studies are creeping into practice within the pharma world, but how about science classrooms?
More DetailsIgniteData Named as a Game Changer in the Thames Valley for 2017
The Thames Valley is rich in established, mature tech-based businesses – that’s clear. What about the young start-ups?
More Details